Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression
Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression
复制标题
DOI:
10.1677/joe.1.06585
复制
发表时间:
2006-03-01
影响因子:
4
通讯作者:
López-Calderón, A
中科院分区:
文献类型:
--
作者:
Granado, M;Martin, AI;López-Calderón, A
Gram-negative bacterial infection or treatment of animals with bacterial lipopolysaccharide (LPS) induces a catabolic state with proteolysis, liver injury and an inhibition of the insulin-like growth factor-I (IGF-I) system. The purpose of this work was to elucidate the role of Kupffer cells in LPS-induced inhibition of the lGF-I/IGF-binding protein-3 (IGFBP-3) system. Adult male Wistar rats were either pretreated with the Kupffer cell inhibitor gadolinium chloride (10 mg/kg, i.v., 24 h prior to LPS exposure) or saline vehicle. Rats received two i.p. injections of 1 mg/kg LPS (at 17:30 and 08:30 h the following day) and were killed 4 h after the second injection. LPS administration induced a significant decrease in body weight and in serum concentrations of IGF-I and IGFBP-3 (P < 0.01), as well as in their gene expression in the liver. LPS-injected rats had increased seruni concentrations of ACTH, corticosterone (P < 0.05), turnout necrosis factor-a (TNF-alpha) and rutrites (P < 0.01). pretreatment of the animals with gadolinium chloride blocked the inhibitory, effect of LPS on body weight, and on serum concentrations of ICF-I, IGFBP-3 and nitrites, as well as growth hormone receptor (GHR), IGF-I and IGFBP-3 gene expression in the liver. In contrast, gadolinium chloride administration did not modify the stimulatory effect of LPS on serurn concentrations of ACTH, corticosterone and TNF-alpha. These results suggest that Kupffer cells are important mediators in the inhibitor effect of LPS on GHR, IGF-I and IGFBP-3 gene expression in the liver, leading to a decrease in serurri concentrations of IGF-I and IGF.BP-3.